Pursuant to the exercise of warrants announced on 5 July 2017, Breedon was informed on 13 July 2017 by Abicad Holding Limited ("Abicad") that as a result of the enlarged issued share capital of the Company, Abicad's percentage holding reduced accordingly to approximately 17.91%. The number of the Company's issued ordinary shares held by Abicad has not changed and remains 259,120,245.
Enquiries:
Breedon Group plc
Pat Ward, Group Chief Executive 01332 694010
Stephen Jacobs, Head of Communications 07831 764592
Cenkos Securities plc (NOMAD)
Max Hartley 020 7397 8900
Numis Securities (Joint Broker)
Heraclis Economides
Ben Stoop 020 7260 1000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.